A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
Launched by UNIVERSITY OF ARIZONA · Oct 15, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a program that combines nutrition and exercise to help American Indian patients with obesity-related cancer before they have surgery. The main goal is to see if this program is practical and acceptable for patients, and to measure how it might change certain markers in the body that indicate inflammation, which can be linked to cancer. The study aims to involve participants who are between 18 and 80 years old, have a diagnosis of certain types of obesity-related cancer (like breast or colorectal cancer), and are planning to have surgery in the near future.
If you or a loved one is interested in participating, you would need to be a member of the San Carlos Apache Nation and scheduled for surgery at a specific healthcare center. Participants will not be receiving chemotherapy during the study and should not have other health conditions that might limit their ability to follow the diet or exercise plan. Throughout the trial, you can expect to take part in this prehabilitation program and provide blood and tissue samples to help researchers understand the effects of the intervention on inflammation. Your involvement could contribute to valuable insights that may help improve care for other patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-80 years
- • Clinical diagnosis of obesity-related solid tumor cancer: obesity-related solid tumor cancers include thyroid, breast, liver, gallbladder, gastric, pancreatic, colorectal, ovarian, uterine, kidney, esophageal cancers.
- • Preoperative status with plan to undergo an operation to remove the tumor
- • Scheduled at least 3 weeks out from the operation
- • Receiving care at San Carlos Apache Healthcare Corporation (SCAHC)
- • Must be having cancer surgery at San Carlos Apache Healthcare Corporation or Banner University Medical Center-Tucson
- Exclusion Criteria:
- • Current or planned receipt of chemotherapy during the preoperative study period
- • Digestive tract disease that would restrict diet modifications
- • Allergy to the foods intended for the nutrition intervention
- • Uncontrolled cardiac disease or other contraindications to moderate-intensity exercise
About University Of Arizona
The University of Arizona is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore new therapeutic approaches and enhance patient outcomes. Committed to ethical research practices and community engagement, the University of Arizona fosters an environment that promotes scientific discovery and the translation of research findings into clinical applications. Its clinical trial initiatives encompass a wide range of medical disciplines, reflecting the institution's mission to improve health and well-being locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tucson, Arizona, United States
Patients applied
Trial Officials
Jennifer Erdrich, MD
Principal Investigator
University of Arizona
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported